View Older Stories

Aug 4, 2025 11:56AM Regeneron Pharma (REGN) PT Raised to $695 at RBC Capital

Jul 2, 2025 10:00AM These 30 global stocks offer tactical and structural upside, says RBC

Jun 4, 2025 05:09AM RBC Capital Reiterates Sector Perform Rating on Regeneron Pharma (REGN)

Jun 3, 2025 09:29AM RBC Capital: 'What's Regeneron Pharma's (REGN) Best Next Move'

Jun 2, 2025 09:36AM RBC Capital Reiterates Sector Perform Rating on Regeneron Pharma (REGN)

May 30, 2025 12:38PM RBC Capital Downgrades Regeneron Pharma (REGN) to Sector Perform

May 29, 2025 09:17AM RBC Capital Previews Regeneron Pharma (REGN): 'Deep Dive Suggests Plenty Of Reasons For Optimism'

May 27, 2025 08:42AM RBC Capital: Regeneron Pharma (REGN) Could Soar on Eylea Spin

Apr 21, 2025 04:05PM Regeneron Announces Investor Conference Presentations

Apr 12, 2025 04:00AM Biotech sector Q1 earnings preview from RBC Capital Markets

Apr 1, 2025 10:00AM RBC makes changes to its flagship 'Top 30 Global Ideas for 2025' list

Feb 5, 2025 11:51AM Regeneron Pharma (REGN) PT Lowered to $1,045 at RBC Capital

Jan 7, 2025 09:13AM Regeneron Pharma (REGN) PT Lowered to $1,184 at RBC Capital

Dec 19, 2024 11:16AM RBC Capital's Game Changers: 'Disruptive Forces in Biotech'

Dec 16, 2024 07:03AM RBC Capital's Global Biotech Outlook Report: 'Top 2025 Ideas'

Sep 23, 2024 04:40PM RBC Capital on Regeneron (REGN): 'We see potential earlier-than-expected launch of biosimilar product as incrementally negative to REGN's story'

Sep 9, 2024 06:24AM Regeneron Pharma (REGN) PT Raised to $1,282 at RBC Capital

Jul 9, 2024 07:00PM 2Q24 U.S. biotech earnings preview

Jun 24, 2024 06:21AM RBC Capital Reiterates Outperform Rating on Regeneron Pharma (REGN)

Jun 12, 2024 06:18AM Regeneron Pharma (REGN) PT Raised to $1,229 at RBC Capital

Jun 4, 2024 07:53AM Regeneron Pharma (REGN) PT Raised to $1,200 at RBC Capital

May 17, 2024 01:43PM RBC Capital Reiterates Outperform Rating on Regeneron Pharma (REGN)

May 6, 2024 04:05PM Regeneron Announces Investor Conference Presentations

May 3, 2024 06:46AM Regeneron Pharma (REGN) PT Lowered to $1,185 at RBC Capital

Apr 11, 2024 11:40AM RBC on Regeneron Pharma (REGN):'The Buying Opportunity Many Have Been Looking For, With Overdone DOJ Downside On Top Of Recent Weakness'

Mar 25, 2024 07:29AM Regeneron's blood cancer therapy faces setback as FDA raises trial concerns

Jan 12, 2024 11:05AM It's as good a time as any to own Regeneron (REGN) - RBC Capital

Apr 11, 2023 04:00PM Regeneron Announces Investor Conference Presentations

Apr 11, 2023 04:00PM Regeneron Announces Investor Conference Presentations

Feb 3, 2023 11:38AM Regeneron shares rise as eczema drug sales help drugmaker post Q4 earnings beat

Sep 8, 2022 10:40AM RBC Capital Comments on on Regeneron Pharma (REGN) Primary Endpoint Data

Jan 11, 2022 06:25AM Regeneron Pharma (REGN) Preannouncement Highlights Evolution Beyond Eylea & Dupixent - RBC

Apr 23, 2021 04:05PM Regeneron Announces Investor Conference Presentations

Dec 30, 2020 06:36AM Regeneron Pharma (REGN) Posts "Middle of the Road" Ph3 Data - RBC

May 26, 2020 08:24AM Sanofi Could Turn Its Attention to BioMarin (BMRN) After Selling Regeneron Stake - RBC

Apr 29, 2020 07:00AM Regeneron Announces Upcoming Investor Conference Presentations

Aug 7, 2019 07:22AM Regeneron Pharma (REGN) PT Raised to $399 at RBC Capital

May 8, 2019 06:59AM Regeneron Pharma (REGN) PT Lowered to $392 at RBC Capital

May 15, 2018 07:56AM Vertex Pharma (VRTX), Alexion Pharma (ALXN) Least Impacted from Trump Drug Policies - RBC

Sep 14, 2017 04:32PM RBC Capital Starts Regeneron Pharma (REGN) at Sector Perform

Nov 1, 2016 07:03AM Pfizer cholesterol drug fizzles, hitting shares

Oct 3, 2016 09:30AM Regeneron (REGN): Ready To Go On Approval Of Dupilumab BLA - RBC

Mar 16, 2016 02:57PM Amgen (AMGN) Patent Wins Increase Likelihood of Settlement, Says RBC

Aug 4, 2015 03:19PM Regeneron Pharma's (REGN) Price Target Boosted to $665 at RBC

Jun 15, 2015 09:03AM RBC Sees Long-Term and Near-Term Upside for Regeneron (REGN); PT to $550

Jun 10, 2015 07:09AM RBC Capital Comments on Regeneron (REGN) Following 'Unexpectedly Cautious' Adcom

Jun 9, 2015 07:05AM Regeneron (REGN) Halted Ahead of FDA Panel Review of Praluent

Jun 5, 2015 09:35AM FDA Breifing Documents for Regeneron's (REGN) Praluent 'Read Well,' Says RBC Capital

Mar 16, 2015 06:53AM RBC Comments on Amgen (AMGN) Repatha Data

Nov 4, 2014 03:28PM Regeneron Pharma (REGN) Price Target Raised to $410 at RBC

View Older Stories